Sherbrooke Park Advisers’s Lifestance Health LFST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-29,151
Closed -$160K 397
2025
Q3
$160K Sell
29,151
-116
-0.4% -$568 0.07% 407
2025
Q2
$151K Sell
29,267
-7,051
-19% -$42.2K 0.07% 422
2025
Q1
$242K Buy
36,318
+5,470
+18% +$41.6K 0.11% 370
2024
Q4
$227K Sell
30,848
-20,993
-40% -$151K 0.07% 534
2024
Q3
$363K Buy
+51,841
New +$312K 0.08% 482

Other funds holding LFST

Sherbrooke Park Advisers's LFST Position: Q4 2025 in Review

Sherbrooke Park Advisers sold out of Lifestance Health (LFST) in Q4 2025, closing a stake of 29,151 shares — an estimated $160K sold.

Sherbrooke Park Advisers first reported a position in LFST in Q3 2024 and held it in 5 quarters. The position peaked at $363K in Q3 2024. 204 funds tracked by Wall St. Rank hold LFST as of Q4 2025.

  • Sherbrooke Park Advisers reported no remaining Lifestance Health position as of Q4 2025 after selling out during the quarter.
  • Sherbrooke Park Advisers sold 29,151 Lifestance Health shares in Q4 2025, an estimated $160K.
  • Sherbrooke Park Advisers first reported a position in Lifestance Health in Q3 2024 and held it in 5 quarters.
  • Sherbrooke Park Advisers's Lifestance Health position peaked at $363K in Q3 2024.
  • 204 funds tracked by Wall St. Rank held Lifestance Health as of Q4 2025.

Based on Sherbrooke Park Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.